Particulate delivery systems for animal vaccines.
The requirements for veterinary vaccines are different to those of human vaccines. Indeed, while more side effects can be tolerated in animals than in humans; there are stricter requirements in terms of cost, ease of delivery (including to wildlife), and a need to develop vaccines in species for which relatively little is known in terms of molecular immunology. By their nature particulate vaccine delivery systems are well suited to address these challenges. Here, we review particulate vaccine delivery systems, ranging from cm-sized long-distance ballistic devices to nano-bead technology for veterinary species and wildlife.
Scheerlinck
Jean-Pierre Y
JP
The Centre for Animal Biotechnology, The University of Melbourne, Vic. 3010, Australia. j.scheerlinck@unimelb.edu.au
Greenwood
Deanne L V
DL
D000276:Adjuvants, Immunologic / Q000008:administration & dosage; D000820:Animal Diseases / Q000517:prevention & control*; D000818:Animals; D016503:Drug Delivery Systems / Q000639:trends* / Q000662:veterinary; D016882:ISCOMs / Q000008:administration & dosage; D008081:Liposomes; D010316:Particle Size; D014612:Vaccines / Q000008:administration & dosage / Q000276:immunology* / Q000494:pharmacology*; D022701:Virosomes
D000276:Adjuvants, Immunologic; D016882:ISCOMs; D008081:Liposomes; D014612:Vaccines; D022701:Virosomes